Flupentixol

Generic Name
Flupentixol
Brand Names
Fluanxol
Drug Type
Small Molecule
Chemical Formula
C23H25F3N2OS
CAS Number
2709-56-0
Unique Ingredient Identifier
FA0UYH6QUO
Background

Flupentixol is an antipsychotic drug of the thioxanthene group. It exists in two geometric isomers, the trans(E) and pharmacologically active cis(Z) forms. Flupentixol decanoate is one of the active ingredients found in injectable drug formulations: it is produced by esterification of cis(Z)‐flupentixol with decanoic acid. Flupentixol is an antagonist of bot...

Indication

Flupentixol is indicated for maintenance therapy of chronic schizophrenic patients whose main manifestations do not include excitement, agitation or hyperactivity.

It is indicated for the management of depression in adult patients who may, or may not, also be showing signs of anxiety.
...

Associated Conditions
Chronic Schizophrenia, Depression, Dysphoria, Neurasthenia
Associated Therapies
-
Clinical Trials
Related News

Adjunctive Use of Fute (Flupentixol) in Multi-acting Receptor-targeted Antipsychotics Treated Schizophrenia Patients

First Posted Date
2021-05-24
Last Posted Date
2021-05-24
Lead Sponsor
Taichung Veterans General Hospital
Target Recruit Count
30
Registration Number
NCT04898270
Locations
🇨🇳

Taichung Veterans General Hospital, Taichung, Taiwan

Pharmacovigilance in Gerontopsychiatric Patients

Phase 3
Terminated
Conditions
Dementia
Depression
Schizophrenia
Psychosomatic Disorders
Anxiety Disorders
Interventions
Drug: Phenobarbital
Drug: Phenytoin
Drug: Carbamazepine
Drug: Oxcarbazepine
Drug: Valproic Acid
Drug: Lamotrigine
Drug: Topiramate
Drug: Gabapentin
Drug: Levetiracetam
Drug: Pregabalin
Drug: Lacosamide
Drug: Clonazepam
Drug: Biperiden
Drug: Levomepromazine
Drug: Fluphenazine
Drug: Perphenazine
Drug: Perazine
Drug: Thioridazine
Drug: Haloperidol
Drug: Melperone
Drug: Pipamperone
Drug: Bromperidol
Drug: Benperidol
Drug: Sertindole
Drug: Ziprasidone
Drug: Flupentixol
Drug: Chlorprothixene
Drug: Zuclopenthixol
Drug: Fluspirilene
Drug: Pimozide
Drug: Clozapine
Drug: Olanzapine
Drug: Quetiapine
Drug: Sulpiride
Drug: Tiapride
Drug: Amisulpride
Drug: Prothipendyl
Drug: Risperidone
Drug: Aripiprazole
Drug: Paliperidone
Drug: Diazepam
Drug: Oxazepam
Drug: Lorazepam
Drug: Bromazepam
Drug: Clobazam
Drug: Alprazolam
Drug: Hydroxyzine
Drug: Buspirone
Drug: Chloral Hydrate
Drug: Flurazepam
Drug: Nitrazepam
Drug: Triazolam
Drug: Lormetazepam
Drug: Temazepam
Drug: Midazolam
Drug: Brotizolam
Drug: Zopiclone
Drug: Zolpidem
Drug: Zaleplon
Drug: Melatonin
Drug: Clomethiazole
Drug: Diphenhydramine
Drug: Promethazine
Drug: Imipramine
Drug: Clomipramine
Drug: Opipramol
Drug: Trimipramine
Drug: Amitriptyline
Drug: Nortriptyline
Drug: Doxepin
Drug: Maprotiline
Drug: Amitriptyline oxide
Drug: Fluoxetine
Drug: Citalopram
Drug: Paroxetine
Drug: Sertraline
Drug: Fluvoxamine
Drug: Escitalopram
Drug: Tranylcypromine
Drug: Moclobemide
Drug: Mianserin
Drug: Trazodone
Drug: Mirtazapine
Drug: Bupropion
Drug: Venlafaxine
Drug: Reboxetine
Drug: Duloxetine
Drug: Agomelatine
Drug: Pyritinol
Drug: Piracetam
Drug: Donepezil
Drug: Rivastigmine
Drug: Galantamine
Drug: Memantine
Drug: Nicergoline
Drug: Acamprosate
Drug: Lithium
First Posted Date
2015-03-02
Last Posted Date
2018-02-28
Lead Sponsor
Hannover Medical School
Target Recruit Count
407
Registration Number
NCT02374567
Locations
🇩🇪

Bezirkskrankenhaus Augsburg, Augsburg, Germany

🇩🇪

Krankenhaus Hedwigshöhe, Berlin, Germany

🇩🇪

Hannover Medical School, Hannover, Germany

and more 2 locations

Clinical Effectiveness of Newer Antipsychotics in Comparison With Conventional Antipsychotics in Schizophrenia

First Posted Date
2010-07-16
Last Posted Date
2015-06-22
Lead Sponsor
University of Bremen
Target Recruit Count
149
Registration Number
NCT01164059
Locations
🇩🇪

Klinikum Bremen-Ost gGmbH, Bremen, Germany

🇩🇪

Rheinische Kliniken Düsseldorf der Heinrich-Heine-Universität, Düsseldorf, Germany

🇩🇪

Privat-Nerven-Klinik Dr. med. Kurt Fontheim, Liebenburg, Germany

and more 15 locations

Flupenthixol and Haloperidol for Treating Cocaine Abuse Schizophrenics - 9

First Posted Date
1999-09-21
Last Posted Date
2017-01-12
Lead Sponsor
National Institute on Drug Abuse (NIDA)
Target Recruit Count
60
Registration Number
NCT00000274
Locations
🇺🇸

New York State Psychiatric Institute, New York, New York, United States

Flupenthixol Decanoate in Methamphetamine Smoking - 1

Phase 2
Completed
Conditions
Substance-Related Disorders
First Posted Date
1999-09-21
Last Posted Date
2017-01-12
Lead Sponsor
National Institute on Drug Abuse (NIDA)
Target Recruit Count
58
Registration Number
NCT00000241
Locations
🇺🇸

Friends Research Institute, Los Angeles, California, United States

Infusion Laboratory: Protocol 5 (Flupenthixol) - 14

Phase 1
Conditions
Cocaine-Related Disorders
First Posted Date
1999-09-21
Last Posted Date
2017-01-11
Lead Sponsor
National Institute on Drug Abuse (NIDA)
Registration Number
NCT00000349
Locations
🇺🇸

Friends Research Institute, Los Angeles, California, United States

Flupenthixol Treatment in Schizophrenic Cocaine Abusers - 1

Phase 2
Completed
Conditions
Cocaine-Related Disorders
First Posted Date
1999-09-21
Last Posted Date
2017-01-12
Lead Sponsor
National Institute on Drug Abuse (NIDA)
Registration Number
NCT00000266
Locations
🇺🇸

New York State Psychiatric Institute, New York, New York, United States

Cocaine Abuse and ADHD - 10

Phase 2
Completed
Conditions
Cocaine-Related Disorders
First Posted Date
1999-09-21
Last Posted Date
2017-01-12
Lead Sponsor
National Institute on Drug Abuse (NIDA)
Target Recruit Count
16
Registration Number
NCT00000275
Locations
🇺🇸

New York State Psychiatric Institute, New York, New York, United States

© Copyright 2024. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy